These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 8495594

  • 21. Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of Diabetes.
    Rossi L, Parvin S, Hassan Z, Hildebrand P, Keller U, Ali L, Beglinger C, Azad Khan AK, Whitcomb DC, Gyr N.
    Pancreatology; 2004; 4(5):461-7. PubMed ID: 15258409
    [Abstract] [Full Text] [Related]

  • 22. [Type 2 diabetes and beta cell apoptosis].
    Cerasi E, Kaiser N, Leibowitz G.
    Diabetes Metab; 2000 Jun; 26 Suppl 3():13-6. PubMed ID: 10945145
    [Abstract] [Full Text] [Related]

  • 23. Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis.
    von Tirpitz C, Glasbrenner B, Mayer D, Malfertheiner P, Adler G.
    Hepatogastroenterology; 1998 Jun; 45(22):1111-6. PubMed ID: 9756016
    [Abstract] [Full Text] [Related]

  • 24. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
    Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Holst JJ, Krarup T.
    Regul Pept; 2007 Dec 04; 144(1-3):123-30. PubMed ID: 17692937
    [Abstract] [Full Text] [Related]

  • 25. [Significance of pancreatic polypeptide in gastrointestinal diseases].
    Petritsch W, Leb G, Pristautz H.
    Acta Med Austriaca; 1985 Dec 04; 12(5):139-43. PubMed ID: 3832746
    [Abstract] [Full Text] [Related]

  • 26. [Epidemiology of diabetes mellitus: prevalence, incidence, pathogenesis, and prognosis].
    Janka HU, Michaelis D.
    Z Arztl Fortbild Qualitatssich; 2002 Mar 04; 96(3):159-65. PubMed ID: 12017759
    [Abstract] [Full Text] [Related]

  • 27. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J.
    Regul Pept; 2005 Jun 15; 128(2):149-57. PubMed ID: 15780434
    [Abstract] [Full Text] [Related]

  • 28. Role of glucagon in diabetes.
    Unger RH, Orci L.
    Arch Intern Med; 1977 Apr 15; 137(4):482-91. PubMed ID: 403869
    [Abstract] [Full Text] [Related]

  • 29. Vanished islets with pancreatitis in acute-onset insulin-dependent diabetes mellitus in an adult.
    Kimura N, Fujiya H, Yamaguchi K, Takahashi T, Nagura H.
    Arch Pathol Lab Med; 1994 Jan 15; 118(1):84-8. PubMed ID: 8285838
    [Abstract] [Full Text] [Related]

  • 30. Protection of pancreatic beta-cells: is it feasible?
    Bonora E.
    Nutr Metab Cardiovasc Dis; 2008 Jan 15; 18(1):74-83. PubMed ID: 18096375
    [Abstract] [Full Text] [Related]

  • 31. [Diabetes mellitus caused by pancreatitis in a bull].
    Braun U, Dürr M, Diener M, Ossent P, Hammon H, Blum JW.
    Schweiz Arch Tierheilkd; 2001 Feb 15; 143(2):99-104. PubMed ID: 11234631
    [Abstract] [Full Text] [Related]

  • 32. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B.
    Int J Clin Pract Suppl; 2008 Mar 15; (159):2-7. PubMed ID: 18269435
    [Abstract] [Full Text] [Related]

  • 33. Chronic pancreatitis with secondary diabetes mellitus treated by use of insulin in an adult California sea lion.
    Meegan JM, Sidor IF, Steiner JM, Sarran D, Dunn JL.
    J Am Vet Med Assoc; 2008 Jun 01; 232(11):1707-12. PubMed ID: 18518815
    [Abstract] [Full Text] [Related]

  • 34. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J, Stivrina M, Stoldere Dz, Vigante B, Duburs G.
    Cell Biochem Funct; 2007 Jun 01; 25(6):673-80. PubMed ID: 16986170
    [Abstract] [Full Text] [Related]

  • 35. The key role of islet dysfunction in type II diabetes mellitus.
    Porte D, Kahn SE.
    Clin Invest Med; 1995 Aug 01; 18(4):247-54. PubMed ID: 8549009
    [Abstract] [Full Text] [Related]

  • 36. Pancreatic alpha-cell dysfunction in diabetes.
    Burcelin R, Knauf C, Cani PD.
    Diabetes Metab; 2008 Feb 01; 34 Suppl 2():S49-55. PubMed ID: 18640586
    [Abstract] [Full Text] [Related]

  • 37. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A.
    Dan Med Bull; 1999 Jun 01; 46(3):197-234. PubMed ID: 10421979
    [Abstract] [Full Text] [Related]

  • 38. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 01; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 39. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005 Jun 01; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 40. Glucagon and diabetes mellitus.
    Reach G, Assan R.
    Diabete Metab; 1979 Mar 01; 5(1):63-70. PubMed ID: 376365
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.